GLUE
NASDAQStockMonte Rosa Therapeutics, Inc.
$16.03-0.01 (-0.06%)
52-Week Range
$3.70
$25.31
Key Stats
Market Cap
1.0B
P/E Ratio
—
Dividend Yield
—
Beta
1.64
Volume
596.5K
Avg Volume
956.9K
Performance
1M
-10.49%
3M
-2.49%
6M
+147.91%
YTD
+4.77%
1Y
+138.34%
3Y
+128.82%
5Y
-24.27%
Price Chart
ETF Exposure
GLUE is held by 93 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| BBC | Virtus Biotech Clinical Trials ETF | 0.76% |
| PTH | Invesco Dorsey Wright Healthcare Momentum ETF | 0.72% |
| DWAS | Invesco Dorsey Wright SmallCap Momentum ETF | 0.44% |
| FSML | Franklin Small Cap Enhanced ETF | 0.31% |
| CURE.AX | Global X - S&P Biotech ETF | 0.24% |
| XBI | State Street SPDR S&P Biotech ETF | 0.24% |
| SQLV | Royce Quant Small-Cap Quality Value ETF | 0.21% |
| IWC | iShares Micro-Cap ETF | 0.17% |
| AVUV | Avantis U.S. Small Cap Value ETF | 0.16% |
| TNXT | T. Rowe Price Innovation Leaders ETF | 0.13% |
| VFMO | Vanguard U.S. Momentum Factor ETF | 0.11% |
| ACSG | American Century Small Cap Growth Insights ETF | 0.10% |
| AVSC | Avantis U.S. Small Cap Equity ETF | 0.09% |
| TMSL | T. Rowe Price Small-Mid Cap ETF | 0.09% |
| SBIO.L | Invesco NASDAQ Biotech UCITS ETF | 0.09% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.08% |
| IBB | iShares Biotechnology ETF | 0.07% |
| PWS | Pacer WealthShield ETF | 0.07% |
| VTWV | Vanguard Russell 2000 Value ETF | 0.06% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.06% |
| IWN | iShares Russell 2000 Value ETF | 0.06% |
| RFLR | Innovator U.S. Small Cap Managed Floor ETF | 0.06% |
| LABU | Direxion Daily S&P Biotech Bull 3X ETF | 0.05% |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.05% |
| VMO.TO | Vanguard Global Momentum Factor ETF | 0.05% |
| PSC | Principal U.S. Small-Cap Multi-Factor ETF | 0.04% |
| EES | WisdomTree U.S. SmallCap Fund | 0.03% |
| VTWO | Vanguard Russell 2000 ETF | 0.03% |
| RSSL | Global X - Russell 2000 ETF | 0.03% |
| R2SC.L | State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc) | 0.03% |
| GSSC | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF | 0.03% |
| IWM | iShares Russell 2000 ETF | 0.03% |
| SC0K.DE | Invesco Russell 2000 UCITS ETF | 0.03% |
| XSU.TO | iShares U.S. Small Cap Index ETF (CAD-Hedged) | 0.03% |
| DFAS | Dimensional - US Small Cap ETF | 0.03% |
| ISCV | iShares Morningstar Small-Cap Value ETF | 0.03% |
| JKL | iShares Morningstar Small-Cap Value ETF | 0.03% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.03% |
| XRS2.DE | Xtrackers Russell 2000 UCITS ETF 1C | 0.03% |
| XRSU.L | Xtrackers Russell 2000 UCITS ETF 1C | 0.03% |
| OMFS | Invesco Russell 2000 Dynamic Multifactor ETF | 0.02% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.02% |
| UWM | ProShares - Ultra Russell2000 | 0.02% |
| AVSU | Avantis Responsible U.S. Equity ETF | 0.02% |
| VXF | Vanguard Extended Market ETF | 0.02% |
| URTY | ProShares - UltraPro Russell2000 | 0.01% |
| ISCB | iShares Morningstar Small-Cap ETF | 0.01% |
| JKJ | iShares Morningstar Small-Cap ETF | 0.01% |
| VHT | Vanguard Health Care ETF | 0.01% |
| CBUG.DE | iShares $ Treasury Bond 3-7yr UCITS ETF | 0.01% |
Page 1 of 2Next
About GLUE ETF Exposure
Monte Rosa Therapeutics, Inc. (GLUE) is held by 93 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 1.0B, GLUE is a widely held institutional stock. The stock currently trades at $16.03. Investors can gain exposure to GLUE through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold GLUE, sorted by portfolio weight.